Effects of the administration of high-dose aspirin in the polysystic ovary syndrome patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14005116

Enrollment

Unknown

Registered

2014-08-18

Start date

2014-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polysystic ovary syndrome

Interventions

1:900mg/d aspirin for 21days

2:900mg/d aspirin+Yasmin 1 tablet/d for 21days

3:900mg/d aspirin+Yasmin 1 tablet/d for 21days

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: the PCOS patients aged from 18 to 40.

Exclusion criteria

Exclusion criteria: peptic ulcer, indigestion, ketoacidosis, autoimmune diseases

Design outcomes

Primary

Measure	Time frame
fasting blood glucose;fasting insulin;2hour post-prandial blood glucose;testosterone;adiponectin;blood lipids;	—

Countries

China

Contacts

Public ContactChen Zijiang

chenzijiang@vip.163.com+86 13505316618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026